April 30, 2015
Duesseldorf, April 30, 2015 – At its meeting following today’s Annual General Meeting, the Supervisory Board of Gerresheimer AG elected Dr. Axel Herberg (57) as...
More April 14, 2015
Revenues up 1.4% to EUR 301.8m (organic growth -2.4%) Adjusted EBITDA growth of 7.2% to EUR 51.0m (Q1 2014: EUR 47.6m) Net income climbs 22.8% to EUR 12.7m...
More February 11, 2015
Revenues up 1.9% (3.7% organically) to EUR 1,290.0m Adjusted EBITDA totals EUR 258.5m at constant exchange rates Earnings per share up 6.6% to EUR 2.11 ...
More October 22, 2014
Düsseldorf/Dongguan City (People’s Republic of China), October 22, 2014 – Gerresheimer AG, an internationally leading partner to the pharma and healthcare...
More October 08, 2014
Gerresheimer sees good growth opportunities in long-term megatrends of pharma and healthcare Growing importance of drug delivery and dosage devices in Western...
More 